EATRIS focuses on preclinical and early clinical development of drugs, vaccines and diagnostics. Solutions are provided in the fields of advanced therapy medicinal products, biomarkers, imaging and tracing, small molecules and vaccines. The wide-ranging services portfolio focuses on supporting early decision-making and de-risking of projects with a focus on safe and efficient progression into clinical development.
Examples include validation and development of in vitro and in vivo biomarkers for patient stratification, molecular imaging tracers for drug development programs, GMP manufacturing of cellular therapy products, patient-derived xenograft models and many more highly specialized services.